ePI Marks the Shift Toward a Data-Driven Pharma World
Electronic product information (ePI) is fundamentally changing how pharmaceutical companies handle product information: moving away from document-based, manually maintained content toward structured, machine-readable data that can be managed centrally. In an interview with the Handelsblatt special publication "Future of Healthcare," Jessica Giardini, Head of the Pharma Division at mt-g, explains why ePI goes far beyond a regulatory format change, making product information part of a company-wide data strategy for the first time. A central theme is the role of artificial intelligence: AI can support translation, consistency checks, and the assessment of change impacts, but it exposes existing data problems rather than solving them. As Giardini points out, the decisive factor is therefore not which AI solution a company chooses, but whether its own data is fit for AI use in the first place. mt-g supports pharmaceutical companies through this transformation, mediating between regulatory requirements and technical possibilities.
